Procedure for the undifferentiated or myeloid lineage biased expansion of haematopoietic stem cells from umbilical cord blood, mobilized peripheral blood or bone marrow
作者： Alba Casamayor Genesca , Joan Garcia Lopez , Arnau Pla Calvet , Jordi Joan Cairo Badillo
DOI:
关键词:
摘要: Procedure for the undifferentiated or myeloid lineage biased expansion of haematopoietic stem cells coming from umbilical cord blood, mobilized peripheral blood bone marrow. (HSCs). More specifically, present invention relates to a procedure HSCs marrow blood. Said comprises steps culturing purified CD34+ at constant volume, said variable volume and conditioning transplantation. With this dose which is necessary their clinical use produced reproducibly, robustly safely.
lens.org 参考文章(23)
Judy Carol Young, Lesley Jean Murray, Robert J. Tushinski, Expanded and genetically modified populations of human hematopoietic stem cells ,(1999)
Walter Elliott Goldstein, Warren Keene Miller, Transfusable oxygenating composition ,(2000)
Donald Lavelle, Joseph De Simone, Yogen Saunthararajah, Mohammed Milhem, Ronald Hoffman, Nadim Mahmud, Methods for in vitro expansion of hematopoietic stem cells ,(2003)
MALCOLM H. PURDY, CHRISTOPHER J. HOGAN, LISA HAMI, IAN McNIECE, WILBUR FRANKLIN, ROY B. JONES, SCOTT I. BEARMAN, RONALD J. BERENSON, PABLO J. CAGNONI, SHELLEY HEIMFELD, ELIZABETH J. SHPALL, Large Volume Ex Vivo Expansion of CD34-Positive Hematopoietic Progenitor Cells for Transplantation Journal of hematotherapy. ,vol. 4, pp. 515- 525 ,(1995) , 10.1089/SCD.1.1995.4.515
Lesley J Murray, Judy C Young, Linda J Osborne, Karin M Luens, Roland Scollay, Beth L Hill, Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy-1+ cells into rapid division Experimental Hematology. ,vol. 27, pp. 1019- 1028 ,(1999) , 10.1016/S0301-472X(99)00031-4
Monica Gunetti, Ivana Ferrero, Deborah Rustichelli, Massimo Berger, Loretta Gammaitoni, Fabio Timeus, Wanda Piacibello, Massimo Aglietta, Franca Fagioli, Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions. Experimental Hematology. ,vol. 36, pp. 235- 243 ,(2008) , 10.1016/J.EXPHEM.2007.08.030
Hera Andrade-Zaldívar, Leticia Santos, Antonio De León Rodríguez, Expansion of human hematopoietic stem cells for transplantation: trends and perspectives Cytotechnology. ,vol. 56, pp. 151- 160 ,(2008) , 10.1007/S10616-008-9144-1
Jo-Anne H. van Burik, Todd E. DeFor, Margaret L. MacMillan, Michele R. O’Brien, John E. Wagner, Juliet N. Barker, Rachael E. Hough, Serious Infections after Unrelated Donor Transplantation in 136 Children: Impact of Stem Cell Source Biology of Blood and Marrow Transplantation. ,vol. 11, pp. 362- 370 ,(2005) , 10.1016/J.BBMT.2005.02.004
N. Jelinek, S. Schmidt, U. Hilbert, S. Thoma, M. Biselli, C. Wandrey, Novel Bioreactors for the ex vivo Cultivation of Hematopoietic Cells Engineering in Life Sciences. ,vol. 2, pp. 15- 18 ,(2002) , 10.1002/1618-2863(200201)2:1<15::AID-ELSC15>3.0.CO;2-5
S Heimfeld, HLA-identical stem cell transplantation: is there an optimal CD34 cell dose? Bone Marrow Transplantation. ,vol. 31, pp. 839- 845 ,(2003) , 10.1038/SJ.BMT.1704019